Use of Metformin and Vildagliptin for Treatment of Type 2 Diabetes in the Elderly

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s65327
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Vildagliptin: Optimal Control in Type 2 Diabetes Mellitus Treatment

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Metformin Remains the Best Treatment for Type 2 Diabetes

BMJ
2007English

Metformin as First-Line Treatment for Type 2 Diabetes

The Lancet
Medicine
2018English

A Prospective Open Labelled Study of Effect of Vildagliptin With Metformin in Patients With Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2019English

Safe and Effective Prescription of Metformin in Elderly Patients With Type 2 Diabetes (T2DM)

Endocrinology&Metabolism International Journal
2018English

Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

Metformin and Vildagliptin Combination: A New Approach of Endothelial Nitric Oxide Synthase Activity Regulation and Metabolism in Diabetes Mellitus Type 2

Reviews on Clinical Pharmacology and Drug Therapy
2018English

Metformin Use and Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus

MVP Journal of Medical Sciences
2016English

Pdb18 - Clinical & Economic Effectiveness of Using Vildagliptin in Adult Patients With Type 2 Diabetes Undergoing Metformin Monotherapy With Unsatisfactory Glycemic Control

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy